Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Roll-over Study to Allow Continued Access to Ribociclib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
- Status
- COMPLETED
- Phase
- N/A
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m
- Status
- COMPLETED
- Phase
- N/A
A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors
- Status
- COMPLETED
- Phase
- N/A
Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period
- Status
- UNKNOWN
- Phase
- N/A
Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea
- Status
- COMPLETED
- Phase
- N/A
Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
- Status
- UNKNOWN
- Phase
- PHASE4
Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- N/A
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies
- Status
- COMPLETED
- Phase
- N/A